Access to emergency eye care remains a public health challenge, with gaps that affect patients and communities across the ...
Artificial intelligence (AI) could help close gaps in eye care for underserved communities, but only if the tools reach the ...
The opening session of AAO 2026 featured a keynote speech discussing how artificial intelligence (AI) will play a part in ...
At the American Academy of Ophthalmology (AAO) 2026 Annual Meeting, Michael F. Chiang, MD, director of the National Eye ...
Overall, the researchers concluded that GLP-1RAs had a protective association with the development of DME compared with ...
Adults with colorectal cancer (CRC) in states that expanded Medicaid under the Affordable Care Act (ACA) had lower mortality ...
Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...
Michael Mina, MD, PhD, explains LIBERTY trial findings on VYD2311 tolerability alone and given with an mRNA COVID-19 vaccine.
The FDA has approved olanzapine extended-release injectable suspension (Weltruza; Teva Pharmaceuticals), a once-monthly ...
Projectiles such as grass, dirt, and rocks caused 77% of injuries, and eye protection, including eyeglasses, was documented ...
Amanda Velazquez, MD, discusses GLP-1 formulary strategies, overcoming prior authorization hurdles, and building scalable ...
Older adults on Medicare report the best access to care among 10 countries but more cost-related problems and higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results